<p>(A) Western blot analyses for GRP94 and GRP78 in MKN45 cells treated with honokiol for 8 h in a dose-response manner. (B) Western blot analyses for GRP94 and GRP78 in MKN45 cells treated with honokiol (a, 20µM; b, 40 µM) in a time-response manner. (C) Comparison of GRP94 protein expression among human gastric cancer cell lines (SCM-1, AGS, N87, and MKN45), tumor isolated from MKN45 cells-inoculated mice (T), normal mouse gastric epithelium tissue (N), and human umbilical vein endothelial cells (HUVEC). All results shown are representative of at least four independent experiments.</p
<p>(<b>a</b>) KB-3-1 cells and (<b>b</b>) KB-8-5 cells were treated with 5, 10, 15 µg/ml of honokiol...
<p>Cells were treated with honokiol (20–60 µM) for various time courses as indicated. (A) Calpain-I ...
<p>KB-3-1 and KB-8-5 cells were treated with 5 µg/ml of honokiol for short time (0.5, 1, or 2 h) or ...
<p>Western blot analyses for GRP94 and GRP78 in cells (N87 (A), AGS (B), MKN45 (C) and SCM-1 (D)) tr...
<p>(A) Western blot analyses for PARP and GADD153 in MKN45 cells treated with honokiol for 8 h in a ...
<p>(A) The p-STAT-3 (Tyr705) expressions in gastric cancer cells (AGS) and HUVECs treated with honok...
<p>Cells were treated with honokiol (HK) for various time courses as indicated. (A) Cells were treat...
BACKGROUND: Honokiol, a small molecular weight natural product, has been shown to possess potent ant...
Honokiol, a small molecular weight natural product, has been shown to possess potent anti-neoplastic...
<p>AGS (A) and MKN45 (B) quiescent human gastric cancer cells and HUVECs (C) were treated with and w...
Background: Honokiol, a small-molecular weight natural product, has previously been reported to acti...
Honokiol, a small-molecular weight natural product, has previously been reported to activate apoptos...
<p>[<sup>18</sup>F]-FDG-PET served as a surrogate measure of therapeutic efficacy. Tumors in nude mi...
<p>(A) MiaPaCa and Panc1 cells were treated with either honokiol (20, 40 or 60 µM) or DMSO (control)...
<p>(<b>a, b</b>) Growth inhibition effect of paclitaxel and p-gp expression in KB-3-1, KB-8-5, KB-C1...
<p>(<b>a</b>) KB-3-1 cells and (<b>b</b>) KB-8-5 cells were treated with 5, 10, 15 µg/ml of honokiol...
<p>Cells were treated with honokiol (20–60 µM) for various time courses as indicated. (A) Calpain-I ...
<p>KB-3-1 and KB-8-5 cells were treated with 5 µg/ml of honokiol for short time (0.5, 1, or 2 h) or ...
<p>Western blot analyses for GRP94 and GRP78 in cells (N87 (A), AGS (B), MKN45 (C) and SCM-1 (D)) tr...
<p>(A) Western blot analyses for PARP and GADD153 in MKN45 cells treated with honokiol for 8 h in a ...
<p>(A) The p-STAT-3 (Tyr705) expressions in gastric cancer cells (AGS) and HUVECs treated with honok...
<p>Cells were treated with honokiol (HK) for various time courses as indicated. (A) Cells were treat...
BACKGROUND: Honokiol, a small molecular weight natural product, has been shown to possess potent ant...
Honokiol, a small molecular weight natural product, has been shown to possess potent anti-neoplastic...
<p>AGS (A) and MKN45 (B) quiescent human gastric cancer cells and HUVECs (C) were treated with and w...
Background: Honokiol, a small-molecular weight natural product, has previously been reported to acti...
Honokiol, a small-molecular weight natural product, has previously been reported to activate apoptos...
<p>[<sup>18</sup>F]-FDG-PET served as a surrogate measure of therapeutic efficacy. Tumors in nude mi...
<p>(A) MiaPaCa and Panc1 cells were treated with either honokiol (20, 40 or 60 µM) or DMSO (control)...
<p>(<b>a, b</b>) Growth inhibition effect of paclitaxel and p-gp expression in KB-3-1, KB-8-5, KB-C1...
<p>(<b>a</b>) KB-3-1 cells and (<b>b</b>) KB-8-5 cells were treated with 5, 10, 15 µg/ml of honokiol...
<p>Cells were treated with honokiol (20–60 µM) for various time courses as indicated. (A) Calpain-I ...
<p>KB-3-1 and KB-8-5 cells were treated with 5 µg/ml of honokiol for short time (0.5, 1, or 2 h) or ...